Connection
Jennifer Diamond to Cyclin-Dependent Kinase 9
This is a "connection" page, showing publications Jennifer Diamond has written about Cyclin-Dependent Kinase 9.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.202 |
|
|
|
-
Diamond JR, Boni V, Lim E, Nowakowski G, Cordoba R, Morillo D, Valencia R, Genvresse I, Merz C, Boix O, Frigault MM, Greer JM, Hamdy AM, Huang X, Izumi R, Wong H, Moreno V. First-in-Human Dose-Escalation Study of Cyclin-Dependent Kinase 9 Inhibitor VIP152 in Patients with Advanced Malignancies Shows Early Signs of Clinical Efficacy. Clin Cancer Res. 2022 04 01; 28(7):1285-1293.
Score: 0.202